Literature DB >> 26998152

Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling.

Shujie He1, Juan Lin2, Shaoping Yu3, Shijie Sun3.   

Abstract

Phosphatidylinositol-3,4,5-trisphosphate Rac exchanger 2 (PREX2), a regulator of the small guanosine triphosphatase Rac, demonstrates an inhibitory effect on the activity of phosphatase and tensin homolog (PTEN). Previously, PREX2 was implicated in the regulation of cell invasion in hepatocellular carcinoma (HCC). However, the exact role of PREX2 in the regulation of HCC cell proliferation and migration, as well as the underlying mechanisms, remains unclear. In the present study, reverse transcription-quantitative polymerase chain reaction revealed that PREX2 was upregulated in HCC tissue compared with matched adjacent non-tumorous tissue. In addition, the present study demonstrated that the messenger RNA and protein levels of PREX2 increased in human HCC HepG2, LH86, LMH and PLHC-1 cell lines compared with normal human liver THLE-3 cells. Overexpression of PREX2 significantly enhanced the proliferation and migration of HCC cells, and knockdown of PREX2 expression significantly suppressed the proliferation and migration of HCC cells. Additional investigation revealed that overexpression of PREX2 suppressed the activity of PTEN, leading to an enhancement in the activity of protein kinase B (AKT). By contrast, knockdown of PREX2 expression upregulated the activity of PTEN and suppressed the activity of AKT. Overall, the present study suggests that PREX2 promotes the proliferation and migration of HCC cells by inhibiting PTEN-AKT signaling.

Entities:  

Keywords:  hepatocellular carcinoma; migration; phosphatidylinositol-3,4,5-trisphosphate Rac exchanger 2; proliferation

Year:  2016        PMID: 26998152      PMCID: PMC4774577          DOI: 10.3892/ol.2016.4164

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  P-Rex2, a new guanine-nucleotide exchange factor for Rac.

Authors:  Sarah Donald; Kirsti Hill; Charlotte Lecureuil; Romain Barnouin; Sonja Krugmann; W John Coadwell; Simon R Andrews; Simon A Walker; Phillip T Hawkins; Len R Stephens; Heidi C E Welch
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

Review 2.  Pathways and targets in hepatocellular carcinoma.

Authors:  Amanda Psyrri; Nikolaos Arkadopoulos; Maria Vassilakopoulou; Vassilios Smyrniotis; George Dimitriadis
Journal:  Expert Rev Anticancer Ther       Date:  2012-10       Impact factor: 4.512

Review 3.  Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.

Authors:  Andrew X Zhu
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

4.  miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.

Authors:  Xin Chen; Min Pan; Lulu Han; Hongting Lu; Xiwei Hao; Qian Dong
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

5.  Molecular pathways: P-Rex in cancer.

Authors:  Atanasio Pandiella; Juan Carlos Montero
Journal:  Clin Cancer Res       Date:  2013-06-10       Impact factor: 12.531

6.  miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a.

Authors:  Bo Guo; Liying Liu; Jiayi Yao; Ruili Ma; Dongmin Chang; Zongfang Li; Tusheng Song; Chen Huang
Journal:  Mol Cancer Res       Date:  2013-12-27       Impact factor: 5.852

7.  Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.

Authors:  Barry Fine; Cindy Hodakoski; Susan Koujak; Tao Su; Lao H Saal; Matthew Maurer; Benjamin Hopkins; Megan Keniry; Maria Luisa Sulis; Sarah Mense; Hanina Hibshoosh; Ramon Parsons
Journal:  Science       Date:  2009-09-04       Impact factor: 47.728

8.  MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.

Authors:  Katsuya Ohta; Hiromitsu Hoshino; Jinhua Wang; Shigeshi Ono; Yuuki Iida; Keisuke Hata; Sharon K Huang; Steven Colquhoun; Dave S B Hoon
Journal:  Oncotarget       Date:  2015-02-20

9.  Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.

Authors:  Cindy Hodakoski; Benjamin D Hopkins; Douglas Barrows; Sarah M Mense; Megan Keniry; Karen E Anderson; Philip A Kern; Phillip T Hawkins; Len R Stephens; Ramon Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

10.  Pten dose dictates cancer progression in the prostate.

Authors:  Lloyd C Trotman; Masaru Niki; Zohar A Dotan; Jason A Koutcher; Antonio Di Cristofano; Andrew Xiao; Alan S Khoo; Pradip Roy-Burman; Norman M Greenberg; Terry Van Dyke; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  PLoS Biol       Date:  2003-10-27       Impact factor: 8.029

View more
  7 in total

1.  Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway.

Authors:  Wancheng Qiu; Yanhua Chang; Jing Liu; Xu Yang; Yan Yu; Jiajia Li; Qing Liang; Guangchun Sun
Journal:  Onco Targets Ther       Date:  2020-09-24       Impact factor: 4.147

2.  Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues.

Authors:  Zhijun Liao; Xinrui Wang; Yeting Zeng; Quan Zou
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 3.  The role of autophagy in hepatocellular carcinoma: friend or foe.

Authors:  Lian Liu; Jia-Zhi Liao; Xing-Xing He; Pei-Yuan Li
Journal:  Oncotarget       Date:  2017-04-18

4.  Benzo(a)pyrene promotes Hep-G2 cell migration and invasion by upregulating phosphorylated extracellular signal-regulated kinase expression.

Authors:  Yadong Wang; Teng Pan; Li Li; Haiyu Wang; Ding Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

5.  Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma.

Authors:  Ming-Hui Yang; Chia-Hung Yen; Yen-Fu Chen; Cheng-Chieh Fang; Chung-Hsien Li; Kuo-Jui Lee; Yi-Hsiung Lin; Chien-Hui Weng; Tze-Tze Liu; Shiu-Feng Huang; Bin Tean Teh; Yi-Ming Arthur Chen
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

6.  Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.

Authors:  Fanyun Kong; Delong Kong; Xiaoying Yang; Dongchen Yuan; Ning Zhang; Xuan Hua; Hongjuan You; Kuiyang Zheng; Renxian Tang
Journal:  Cancer Med       Date:  2020-02-04       Impact factor: 4.452

7.  Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer.

Authors:  Zihang Mai; Qianwen Liu; Xinye Wang; Jiaxin Xie; Jianye Yuan; Jian Zhong; Shuogui Fang; Xiuying Xie; Hong Yang; Jing Wen; Jianhua Fu
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.